Terbinafine Tablets (Terbinafine Hydrochloride)
Terbinafine Hydrochloride 140.625mg
Tablet · Prescription medication
HLB Pharma Co., Ltd.
MFDS item code 200101878 · Notified 2001.12.01
This product's status changed to Approval withdrawn on 2024.04.18. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of onychomycosis, dermatomycosis (including tinea pedis and tinea corporis), and tinea capitis
This medication is used in adults for tinea pedis, tinea corporis, tinea cruris, and onychomycosis caused by dermatophytes, and in children for tinea capitis.
Administer terbinafine 125 mg twice daily or 250 mg once daily. The duration of treatment according to the condition is as follows. 1) Dermatophytosis Tinea pedis (interdigital, plantar/moccasin type): 2~6 weeks Tinea corporis: 2∼4 weeks Tinea cruris: 2~4 weeks 2) Onychomycosis Treatment is usually given for 6 weeks~3 months. For infections of the fingernails or relatively small toenails, or in younger patients, the treatment duration may be shortened to 3 months or less. Three months is usually sufficient to treat toenail infections, but treatment may take 6 months or longer in some patients. Treatment may take longer in patients with slow nail growth. 3. Patients with renal impairment For patients with creatinine clearance below 50 mL/min, reduce the daily dose by 1/2.
Administer to children aged 2 years and older. There is no experience with administration in children under 2 years of age; therefore, use is not recommended. Tinea capitis: 4 weeks Tinea capitis occurs primarily in children. To prevent recurrence of infection, treatment should be given regularly for the appropriate prescribed duration. Body weight below 20 kg (under 5 years): Administer 62.5 mg once daily. As experience with administration is limited, the decision to administer should be based on consideration of the benefits and risks of treatment. Body weight 20~40 kg (5~12 years): Administer 125 mg once daily. Body weight over 40 kg (over 12 years): Administer 250 mg once daily.
This medication is not recommended for patients with chronic liver disease or active liver disease. Before taking this medication, liver disease must be confirmed, and regular liver function tests should be performed. Symptoms of liver dysfunction include nausea, loss of appetite, fatigue, vomiting, upper right abdominal pain, jaundice, dark urine, and loose stools, and if any of these symptoms occur, the doctor must be notified immediately. If liver dysfunction is suspected while taking this medication, usage should be discontinued immediately and tests should be conducted. Patients with blood disorders, severely impaired kidney function, children under 2 years of age, and nursing women should avoid this medication. Additionally, if there is an allergy to this medication or its components, use should be avoided. Elderly patients, underweight children, and patients with impaired kidney function should use this medication with extra caution, and if severe rashes or allergic reactions occur, usage should be discontinued immediately. This medication can affect liver function, so it is important to receive monthly liver function tests during the first two months of treatment. Symptoms such as muscle pain, joint pain, headache, taste disturbances, indigestion, and dizziness may occur, and if symptoms worsen, consulting a doctor is advised. This medication can interact with other medications, so it is essential to inform the doctor or pharmacist of any medications being taken. Particularly, dosage adjustments may be needed when taken with medications metabolized in the liver. Women who are pregnant or could become pregnant should carefully consider the benefits and risks of using this medication, and nursing mothers should ideally discontinue breastfeeding while using it. This medication should be stored out of reach of children, away from direct sunlight, and at room temperature. In cases of overdose, symptoms such as headache, nausea, abdominal pain, and dizziness may appear, and immediate medical attention is required.
Persistent nausea, loss of appetite, fatigue, vomiting, right upper abdominal pain, jaundice, dark urine, loose stools, hepatobiliary failure, hepatitis, cholestasis, jaundice, rash, skin itching, fever, nausea, vomiting, anorexia, lethargy, elevated γ-GTP, elevated AST/ALT, elevated LDH, elevated ALP, neutropenia, pancytopenia, agranulocytosis, thrombocytopenia, pharyngitis, fever, lymphadenopathy, purpura, petechiae, leukopenia, anemia, rash, itching, photosensitivity reaction, skin/mucous membrane syndrome, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, erythema multiforme, toxic skin rash, exfoliative dermatitis, blistering dermatitis, psoriasis-type rash, exacerbation of psoriasis, hair loss, musculoskeletal reaction, arthralgia, myalgia, weakness, elevated CPK, increased serum myoglobin, increased urinary myoglobin, hypotension, dyspnea, chest tightness, urticaria, erythema, facial edema, lymphangiectasia, abdominal distension, dyspepsia, mild abdominal pain, diarrhea, discomfort in the upper abdomen, thirst, glossitis, depression, anxiety, headache, taste disturbance, dizziness, drowsiness, sensory abnormalities, sensory loss, decreased attention, insomnia, elevated BUN, increased urinary frequency, visual impairment, tinnitus, anaphylactic reaction, angioedema, systemic lupus erythematosus, elevated total blood cholesterol, increased triglycerides, lethargy, tongue discoloration, palpitations, edema, menstrual irregularities, paralysis, systemic disorders, fever, fatigue, weight loss, anaphylactic reaction, serum sickness-like reaction, blurred vision, decreased vision, hearing loss, auditory impairment, vasculitis, permanent loss of smell, hyposmia, drug rash, pancreatitis, rhabdomyolysis, influenza-like illness, increased blood creatine phosphokinase, headache, nausea, upper abdominal pain, dizziness
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air or moisture from entering, and it is safe to store at room temperature between 1 degree and 30 degrees Celsius. Storing it this way can help maintain the medication’s effectiveness.
White to almost beige round tablets
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Terbinafine Hydrochloride 140.625mg
Tablet · Prescription medication
HLB Pharma Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
GP Therapeutics Korea Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Korea Hutex Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Anguk Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Medica Korea Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Gyeongnam Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Daehwa Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Korea Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.